Cardiomyopathies Clinical Trials in Seoul
2 recruitingSeoul, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled94 locationsNCT06563895
Recruiting
Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in de Novo HFrEF
Heart FailureCardiomyopathiesDeep Learning+2 more
Yonsei University100 enrolled1 locationNCT06978998